What We Offer

PinPoint Data Science develops blood-based cancer screening tests using machine learning. Our PinPoint Lung Screening Test triages asymptomatic patients prior to low-dose CT, ruling out between 20% and 60% of referrals depending on the sensitivity threshold applied, whilst retaining detection of the substantial majority of early-stage (Stage I and II) cancers. We also have numerous test for patients with symptoms that might be cancer. These include: Lower GI, Upper GI (including HPB cancers), Head & Neck, Gynaecological, and Lung.

Note, the lung screening product is new and I do not yet have a descriptive one-pager for the test yet, but expect to soon

What We Are Looking For

We are seeking a KSA-based commercial partner to co-develop a localisation pilot and deploy the PinPoint Lung Screening Test within an asymptomatic screening programme.